Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation
暂无分享,去创建一个
R. Puri | M. Theoret | S. R. Husain | Peter F. Bross | Whitney S. Helms | Ke Liu | P. Bross | Jinhua Lu | Ramjay S. Vatsan | Angelo De Claro | Brian P. Niland